| |
Barbara Willey, A.R.T
Infection Control and Methods Development Technologist
Mount Sinai Hospital, Room 1460
600 University Ave, Toronto Ontario, M5G 1X5
Phone: 416-586-4800 Ext.3121
Fax: 416-586-3140
Email: bwilley@mtsinai.on.ca
 |
Biography
Barbara Willey is the infection control and methods
development technologist for the department of microbiology at
Mount Sinai Hospital. Prior to moving to Canada from South Africa,
Barbara had earned diplomas in clinical microbiology and pathology.
Further training in Canada earned her her clinical microbiology/Advanced
Registered Technologist certification. After working several years
as a bench technologist in the department she took her broad experience
and interests in molecular methodology into her new position as
infection control and methods development technologist. In this
role, she provides supervision for the infection control and molecular
epidemiology activities of the department and provides microbiological
support for the clinical infection control program.
Her research interests include DNA typing systems,
molecular epidemiology and detection methodologies for multi-resistant
organisms. She is also interested in the mechanisms of antibiotic
resistance and is currently investigating third generation cephalosporin
resistance and amp C resistance in E. coli and Klebsiella species.
Her laboratory work also focuses on sub-typing systems and rapid
direct detection methods for MRSA. Aside from her broad clinical
laboratory and research responsibilities, Barbara is also responsible
for supervising a portion of the laboratory research activity
and a number of student projects.
Recent Publications
- Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, Cameron CM, Muller MP, Gold WL, Richardson SE, Poutanen SM, Willey BM, Devries ME, Fang Y, Seneviratne C, Bosinger SE, Persad D, Wilkinson P, Greller LD, Somogyi R, Humar A, Keshavjee S, Louie M, Loeb MB, Brunton J, McGeer AJ, Kelvin DJ
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in severe acute respiratory syndrome (SARS) patients
J Virol Methods Epub ahead of print, 5/30/2007.
- Hanselman BA, Kruth SA, Rousseau J, Low DE, Willey BM, McGeer A, Weese JS.
Methicillin-resistant Staphylococcus aureus colonization in veterinary personnel.
Emerg Infect Dis. 12(12):1933-8, 12/1/2006.
- Louie L, Simor AE, Chong S, Luinstra K, Petrich A, Mahony J, Smieja M, Johnson G, Gharabaghi F, Tellier R, Willey BM, Poutanen S, Mazzulli T, Broukhanski G, Jamieson F, Louie M, Richardson S; Ontario Laboratory Working Group for the Rapid Diagnosis of Emerging Pathogens
Detection of severe acute respiratory syndrome coronavirus in stool specimens by commercially available real-time reverse transcriptase PCR assays
J Clin Microbiol. 44(11):4193-6., 11/1/2006.
- Zhu H, Hu S, Jona G, Zhu X, Kreiswirth N, Willey BM, Mazzulli T, Liu G, Song Q, Chen P, Cameron M, Tyler A, Wang J, Wen J, Chen W, Compton S, Snyder M.
Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray.
Proc Natl Acad Sci U S A 103(11):4011-6., 3/14/2006.
- Weese JS, Dick H, Willey BM, McGeer A, Kreiswirth BN, Innis B, Low DE.
Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household.
Vet Microbiol. 2006 Feb 4; [Epub ahead of print], 2/4/2006.
- Weese JS, Rousseau J, Willey BM, Archambault M, McGeer A, Low DE.
Methicillin-resistant Staphylococcus aureus in horses at a veterinary teaching hospital: frequency, characterization, and association with clinical disease.
J Vet Intern Med. 20(1):182-6., 1/15/2006.
- Drews SJ, Willey BM, Kreiswirth N, Wang M, Ianes T, Mitchell J, Latchford M, McGeer AJ, Katz KC.
Verification of the IDI-MRSA assay for detecting methicillin-resistant Staphylococcus aureus in diverse specimen types in a core clinical laboratory setting.
J Clin Microbiol. 44(10):3794-6., 1/1/2006.
- Arroyo LG, Rousseau J, Willey BM, Low DE, Staempfli H, McGeer A, Weese JS.
Use of a selective enrichment broth to recover Clostridium difficile from stool swabs stored under different conditions.
J Clin Microbiol. 43(10):5341-5343., 10/1/2005.
- Olson AB, Silverman M, Boyd DA, McGeer A, Willey BM, Pong-Porter V, Daneman N, Mulvey MR.
Identification of a progenitor of the CTX-M-9 group of extended-spectrum beta-lactamases from Kluyvera georgiana isolated in Guyana.
Antimicrob Agents Chemother. 49(5):2112-2115., 5/1/2005.
- Weese JS, Archambault M, Willey BM, Hearn P, Kreiswirth BN, Said-Salim B, McGeer A, Likhoshvay Y, Prescott JF, Low DE.
Methicillin-resistant Staphylococcus aureus in horses and horse personnel, 2000-2002.
Emerg Infect Dis. 11(3):430-435., 3/1/2005.
This website has been made possible through an unrestricted educational grant from
Pfizer Canada Inc. |
|
